AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEXTURNBIOSCIENCE Co., LTD Share Issue/Capital Change 2023

Aug 4, 2023

16767_rns_2023-08-04_6e19ed48-6d82-4631-b625-21b66cdc9900.html

Share Issue/Capital Change

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

넥스턴바이오/증권 발행결과(자율공시)/(2023.08.04)증권 발행결과(자율공시)

증권 발행결과(자율공시)


1. 증권의 종류		보통주식
2. 발행방법		제3자배정 유상증자
3. 발행내역	발행예정주식수(주)	139,275
발행예정금액(원)	999,994,500
발행결정 최초 이사회결의일	2023-07-24
실제발행주식수(주)	139,275
실제발행금액(원)	999,994,500
납입일	2023-08-04
4. 상장예정 여부		예
5. 기타 투자판단에 참고할 사항		-
※관련공시	2023-07-24 소액공모공시서류(지분증권) 2023-07-26 소액공모공시서류(지분증권) 2023-07-26 유상증자결정(제3자배정 - 소액공모) 2023-07-27 유상증자결정(제3자배정 - 소액공모) 2023-07-27 소액공모공시서류(지분증권) 2023-07-28 유상증자결정(제3자배정 - 소액공모) 2023-07-28 소액공모공시서류(지분증권)

AI assistant

NEXTURNBIOSCIENCE Co., LTD — Share Issue/Capital Change 2023

16767_rns_2023-08-04_6e19ed48-6d82-4631-b625-21b66cdc9900.html

More from NEXTURNBIOSCIENCE Co., LTD

NEXTURNBIOSCIENCE Co., LTD Share Issue/Capital Change 2023